Inter Pharma Past Earnings Performance
Past criteria checks 2/6
Inter Pharma has been growing earnings at an average annual rate of 18.6%, while the Personal Products industry saw earnings growing at 12.1% annually. Revenues have been growing at an average rate of 38.3% per year. Inter Pharma's return on equity is 1.6%, and it has net margins of 1.5%.
Key information
18.6%
Earnings growth rate
9.5%
EPS growth rate
| Personal Products Industry Growth | 3.7% |
| Revenue growth rate | 38.3% |
| Return on equity | 1.6% |
| Net Margin | 1.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Inter Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,809 | 27 | 597 | 0 |
| 31 Dec 23 | 1,799 | 51 | 568 | 0 |
| 30 Sep 23 | 1,815 | 93 | 555 | 0 |
| 30 Jun 23 | 1,775 | 109 | 540 | 0 |
| 31 Mar 23 | 1,739 | 128 | 513 | 0 |
| 31 Dec 22 | 1,534 | 119 | 458 | 0 |
| 30 Sep 22 | 1,385 | 130 | 390 | 0 |
| 30 Jun 22 | 1,226 | 125 | 339 | 0 |
| 31 Mar 22 | 1,016 | 118 | 284 | 0 |
| 31 Dec 21 | 921 | 105 | 267 | 0 |
| 30 Sep 21 | 760 | 68 | 253 | 0 |
| 30 Jun 21 | 626 | 63 | 230 | 0 |
| 31 Mar 21 | 526 | 56 | 202 | 0 |
| 31 Dec 20 | 447 | 53 | 187 | 0 |
| 30 Sep 20 | 408 | 62 | 162 | 0 |
| 30 Jun 20 | 390 | 57 | 155 | 0 |
| 31 Mar 20 | 389 | 56 | 156 | 0 |
| 31 Dec 19 | 376 | 43 | 157 | 0 |
| 30 Sep 19 | 371 | 28 | 175 | 0 |
| 30 Jun 19 | 365 | 27 | 176 | 0 |
| 31 Mar 19 | 343 | 24 | 169 | 0 |
| 31 Dec 18 | 318 | 30 | 152 | 0 |
| 31 Dec 17 | 248 | 16 | 120 | 0 |
| 31 Dec 16 | 125 | 16 | 59 | 0 |
Quality Earnings: IP-R has high quality earnings.
Growing Profit Margin: IP-R's current net profit margins (1.5%) are lower than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IP-R's earnings have grown by 18.6% per year over the past 5 years.
Accelerating Growth: IP-R's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IP-R had negative earnings growth (-78.6%) over the past year, making it difficult to compare to the Personal Products industry average (27.5%).
Return on Equity
High ROE: IP-R's Return on Equity (1.6%) is considered low.